PTC Therapeutics | PTCT - Net Income



PTC Therapeutics reported $-64849000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Acadia Pharmaceuticals USD 26.67M 7.68M Jun/2025
Alnylam Pharmaceuticals USD -66277000 8.8M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
BioMarin Pharmaceutical USD 240.53M 54.85M Jun/2025
Cytokinetics USD -134370000 27.01M Jun/2025
Daiichi Sankyo JPY 85.5B 1.65B Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
Incyte USD 405M 246.8M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
Novartis USD 4.02B 418M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
PTC Therapeutics USD -64849000 931.41M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sarepta Therapeutics USD 196.89M 644.4M Jun/2025
TG Therapeutics USD 28.19M 23.13M Jun/2025
Ultragenyx Pharmaceutical USD -114951000 36.13M Jun/2025
Vertex Pharmaceuticals USD 1.03B 386.6M Jun/2025
Xencor USD -30825000 17.59M Jun/2025